TMCnet News

Artificial Intelligence (AI) in Genomics Market to Surpass US$ 19.72 Billion by 2030 - Coherent Market Insights
[November 22, 2023]

Artificial Intelligence (AI) in Genomics Market to Surpass US$ 19.72 Billion by 2030 - Coherent Market Insights


BURLINGAME, Calif., Nov. 22, 2023 /PRNewswire/ -- According to Coherent Market Insights, Global Artificial Intelligence (AI) in Genomics market size was valued at US$ 1.15 Billion in 2023 and is expected to surpass US$ 19.72 Billion by 2030 and is anticipated to witness a compound annual growth rate (CAGR) of 50.1% from 2023 to 2030. The global artificial intelligence (AI) in genomics market is experiencing strong growth owing to the increasing biomedical and genomic datasets, growing adoption of AI-based solutions, rising focus on reducing turnaround time in drug discovery & diagnostics.

Coherent_Market_Insights_Logo

Key Trends and Analysis of the Global Artificial Intelligence (AI) in Genomics Market:

The increasing volume of genomic data requires advanced analytics, and AI plays a crucial role in deciphering complex genetic informatics quickly and accurately. AI also accelerates drug discovery to identify potential targets, predicts drug responses and streamline the development process, reducing time and cost. Growing awareness among healthcare professionals and the public about the benefits of AI in genomics is augmenting acceptance and demand for AI technologies in the genomics market.

Request Sample Copy of this Report @
https://www.coherentmarketinsights.com/insight/request-sample/6127

Key Market Takeaways:

Global artificial intelligence (AI) in genomics market is expected to surpass US$ 19.72 Billion by 2030 and is anticipated to witness a CAGR of 50.1% during the forecast period 2023-2030, owing to advancement in precision medicine, rising awareness and education among healthcare professionals, and collaboration between AI companies and genomic research institutions.

On the basis of Delivery Mode, On-Premises Segment is expected to dominate position in the global artificial intelligence (AI) in genomics market during the projected period as these solutions provide flexibility to customize and scale AI application according to specific research needs.

On the basis of Functionality, Genome Sequencing Segment is poised to lead the global artificial intelligence (AI) in genomics market in anticipated timeframe owing to the integration of AI in genomics facilitates fast and more accurate interpretation of genomic information adding in disease diagnosis and treatment customization.

On the basis of Application, Translational Precision Medicine segment is likely to dominate the global market as it translational precision medicine helps in enhancing the analysis of vast genomic data sets, enabling more accurate disease identification, and personalized treatment strategies.

On the basis of End User, Pharma and Biotech Companies segment is expected to hold dominant position in the global market as pharma companies are leveraging AI to analyze vast genomics datasets, accelerating drug discovery, and development processes.

On the basis of Region, North America is poised lead the market throughout the forecast period owing to the increasing human genome project, and multiple initiatives in the U.S. to sequence numerous patients with new targeted diseases, and increasing technological advancement.

Key players in the global artificial intelligence (AI) in genomics market include Fabric Genomics, International Business Machines, MICROSOFT, NVIDIA, AI Therapeutics, Ares Genetics, Benevolent AI, Deep Genomics, DIPLOID and among others.

Global Artificial Intelligence (AI) in Genomics Market Key Developments

In December 2022, Intel Labs and the Perelman School of Medicine at the University of Pennsylvania undertook a collaborative study utilizing distributed machine learning and artificial intelligence techniques in order to assist international health and research organizations in identifying malignant brin tumors,



In March 2021, Hitachi and SPOHiA GENETICS signed a partnership agreement. This partnership helped pharmaceutical companies, as well as healthcare practitioners, gain practical, clinical, and genetic insights that would further democratize data driven precision medicine globally for the benefits of patients.

Read complete market research report, "Artificial Intelligence (AI) in Genomics Market, By Delivery Mode, By Functionality, By Application, By End User, By Region and Segment Forecast 2023 - 2030", Published by Coherent Market Insights.


Global Artificial Intelligence (AI) in Genomics Market Segmentation:

  • By Delivery Mode
    • On-Premises
    • Cloud-based
  • By Functionality
    • Genome Sequencing
    • Gene Editing
    • Others
  • By Application
    • Translational Precision Medicine
    • Clinical & Genomic Diagnostics
    • Others
  • By End User
    • Pharma and Biotech Companies
    • Public and Consumer Genomic Center
    • Others
  • By Region
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC Countries
        • Israel
        • Rest of Middle East & Africa
    • Africa
      • By Country:
        • South Africa
        • North Africa
        • Central Africa

Buy this Premium Research Report Now @
https://www.coherentmarketinsights.com/insight/buy-now/6127

Find more related trending reports below:

Personalized Genomics Market, By Test Type (Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Others), By Technology (PCR-based Tests, Microarray-based Tests, Sequencing-based Tests, Others), By Application (Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition & Health Lifestyle, Others), By End User (Hospitals & Clinics, Research Centers, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Spatial Genomics Transcriptomics Market, By Technology, By Application, By End User, By Sample Type, By Product Type, By End Use Industry, By Research Type, By Workflow Stage, By Collaboration Type, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Genomics and Proteomics Reagents, Research Kits, & Analytical Instrumentation Market, By Product Type (Instrumentation and Analytical Tools (Chromatography, Mass Spectrometry, Thermal Cyclers, Next Gen Sequencing), Reagents and Research Kits (Sample Prep Kits, Electrophoresis Kits, Purification Kits, BioChips)), By End User (Diagnostic Laboratories, Pharmaceutical and Biotechnology Organizations, Research Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Genomics Market by Product Type (Consumables, Software, and Others), by Technology (PCR, Microarray, Next Gene Sequencing, Nucleic Acid Extraction and Purification, and Others), by Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture & Animal Research, and Others), by End Users (Academic and Research Institute, Pharmaceutical & Biotechnology Companies, Hospital and Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

Pharmacogenomics Market, by Technology (DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, and Other Technologies), by Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management and Others), by End User (Hospitals & Clinics, Research Institutions and Academic Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone: 
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: [email protected]
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

Logo : https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/artificial-intelligence-ai-in-genomics-market-to-surpass-us-19-72-billion-by-2030---coherent-market-insights-301995887.html


[ Back To TMCnet.com's Homepage ]